1. Swerdlow SH, Campo E, Harris NL, et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon 2008.
2. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127:2375.
3. Ga-In Lee, Yoon-Duck Kim, Stephanie Ming Young, et al. Clinical characteristics and treatment outcomes of natural killer/T-cell lymphoma involving the ocular adnexa. Br J Ophthalmol. 2019;103(2):269-273.
4. Jiménez-Pérez JC, Yoon MK. Natural killer T-Cell lymphoma of the orbit: an evidencebased approach. Semin Ophthalmol. 2017;32:116–24.
5. Hon C, Kwok AK, Shek TW, et al. Vision-threatening complications of nasal T/NK lymphoma. Am J Ophthalmol. 2002;134:406–10.
6. Yang Y, Luo Q, He W, et al. Primary ocular natural killer/T-cell lymphomas:
clinicopathologic features and diagnosis. Ophthalmologica. 2007;221:173–9.
7. Ely A, Evans J, Sundstrom JM, et al. Orbital involvement in extranodal natural killer T cell lymphoma: an atypical case presentation and review of the literature. Orbit. 2012;31:267–9.
8. Woog JJ, Kim YD, Yeatts RP, et al. Natural killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology 2006;113:140–7.
9. Ferry JA, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol. 2007;31:170–84.
10. Cho EY, Han JJ, Ree HJ, et al. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol. 2003;73:87–96.
11. Al Shawabkeh MA, Al Sulaiti M, Al Sa’ey H, et al. Nasal type extranodal Natural
killer/T (NK/T) cell lymphoma presenting as periorbital cellulitis: a case report. Am J Case Rep. 2016;17:934–8.
12. Kim JW, An JH. Extranodal natural killer/T-cell lymphoma, nasal type, of the orbit mimicking recurrent orbital cellulitis. J Craniofac Surg. 2014;25:509–11.
13. Pine RR, Clark JD, Sokol JA. CD56 negative extranodal NK/T-cell lymphoma of the orbit mimicking orbital cellulitis. Orbit. 2013;32:45–8.
14. Papalkar D, Sharma S, Francis IC, et al. A rapidly fatal case of T-cell lymphoma
presenting as idiopathic orbital inflammation. Orbit. 2005;24:131–3.
15. Kim SJ, Yoon DH, Jaccard A, et al. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016; 17:389.
16. Kanavaros P, Lescs MC, Brière J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 1993; 81:2688.
17. Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, et al. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol. 1998; 11:754.
18. Chan JK, Ng CS, Lau WH, Lo ST. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol. 1987; 11:418.
19. Ferry JA, Sklar J, Zukerberg LR, Harris NL. Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol. 1991; 15:268.
20. Ho FC, Choy D, Loke SL, et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol. 1990; 21:1041.
21. Li YY, Feng LL, Niu SQ, et al. Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy. Oncotarget. 2017; 8:11480.
22. Qi SN, Yang Y, Song YQ, et al. First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020; 4:3141.
23. Li YX, Yao B, Jin J, et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol. 2006; 24:181.